Biotech

Wayne Grube Jr. built upon six decades of family manufacturing experience to help create SEAL Hemostatic Wound Spray as TEDCO invests in Baltimore innovation (BALTIMORE – August 4, 2026) — Behind BC3 Technologies’ projected 500% revenue growth, its FDA-cleared wound spray and a new $200,000 investment from TEDCO is a Baltimore family manufacturing story that began more than six decades ago. Wayne Grube Jr., the Black CEO and co-founder of Baltimore-based BC3 Technologies, did not enter the medical technology industry from nowhere. His father, Wayne Grube Sr., began working in the filling and packaging industry in 1964. After approximately 36…